Skip to main content
    • Aa
    • Aa

Recent advances in understanding the molecular basis of group B Streptococcus virulence

  • Heather C. Maisey (a1), Kelly S. Doran (a2) and Victor Nizet (a1) (a3)

Group B Streptococcus commonly colonises healthy adults without symptoms, yet under certain circumstances displays the ability to invade host tissues, evade immune detection and cause serious invasive disease. Consequently, Group B Streptococcus remains a leading cause of neonatal pneumonia, sepsis and meningitis. Here we review recent information on the bacterial factors and mechanisms that direct host–pathogen interactions involved in the pathogenesis of Group B Streptococcus infection. New research on host signalling and inflammatory responses to Group B Streptococcus infection is summarised. An understanding of the complex interplay between Group B Streptococcus and host provides valuable insight into pathogen evolution and highlights molecular targets for therapeutic intervention.

Corresponding author
*Corresponding author: Victor Nizet, Professor of Pediatrics and Pharmacy, University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Drive, La Jolla, CA 92093-0687, USA. Tel:  + 1 858 534 7408; Fax:  + 1 858 534 5611; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1 A.K. Johri (2006) Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol 4, 932-942

3 J.R. Campbell (2000) Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 96, 498-503

4 C. Beckmann (2002) Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun 70, 2869-2876

5 Q. Cheng (2002) The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect Immun 70, 2408-2413

6 C.K. Brown (2005) Structure of the streptococcal cell wall C5a peptidase. Proc Natl Acad Sci U S A 102, 18391-18396

7 P.P. Cleary (2004) Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice. Vaccine 22, 4332-4341

8 G.S. Tamura (2006) High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity. Infect Immun 74, 5739-5746

10 A. Schubert (2004) The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun 72, 6197-6205

11 U. Samen (2007) The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect Immun 75, 5405-5414

12 R. Seepersaud (2005) Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity. Infect Immun 73, 1671-1683

14 F.G. Sauer (2000) Bacterial pili: molecular mechanisms of pathogenesis. Curr Opin Microbiol 3, 65-72

15 R. Rosini (2006) Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol Microbiol 61, 126-141

16 S. Dramsi (2006) Assembly and role of pili in group B streptococci. Mol Microbiol 60, 1401-1413

17 H.C. Maisey (2007) Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol 189, 1464-1467

18 V. Krishnan (2007) An IgG-like domain in the minor pilin GBS52 of Streptococcus agalactiae mediates lung epithelial cell adhesion. Structure 15, 893-903

19 R.P. Galask (1984) Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 148, 915-928

22 C.E. Rubens (1991) Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J Infect Dis 164, 320-330

25 P. Valentin-Weigand (1997) Characterization of group B streptococcal invasion in HEp-2 epithelial cells. FEMS Microbiol Lett 147, 69-74

27 T. Tenenbaum (2007) Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb. Microbes Infect 9, 714-720

28 E.E. Adderson (2003) Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun 71, 6857-6863

29 G.R. Bolduc (2002) The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell Microbiol 4, 751-758

30 J. Li (1997) Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus. Proc Natl Acad Sci U S A 94, 13251-13256

31 M.J. Baron (2004) Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J Biol Chem 279, 24714-24723

32 M.J. Baron (2007) Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B streptococci into host cells. J Biol Chem 282, 10526-10536

33 G.R. Bolduc and L.C. Madoff (2007) The group B streptococcal alpha C protein binds alpha1beta1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells. Microbiology 153, 4039-4049

35 C.A. Burnham , S.E. Shokoples and G.J. Tyrrell (2007) Rac1, RhoA, and Cdc42 participate in HeLa cell invasion by group B streptococcus. FEMS Microbiol Lett 272, 8-14

36 Q.Q. Wang (2008) Integrin beta 1 regulates phagosome maturation in macrophages through Rac expression. J Immunol 180, 2419-2428

37 C.A. Burnham , S.E. Shokoples and G.J. Tyrrell (2007) Invasion of HeLa cells by group B streptococcus requires the phosphoinositide-3-kinase signalling pathway and modulates phosphorylation of host-cell Akt and glycogen synthase kinase-3. Microbiology 153, 4240-4252

39 R.L. Gibson , V. Nizet and C.E. Rubens (1999) Group B streptococcal β-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 45, 626-634

40 K.S. Doran (2002) Group B streptococcal β-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis 185, 196-203

41 M.E. Hensler (2005) Virulence role of group B Streptococcus β-hemolysin/cytolysin in a neonatal rabbit model of early-onset pulmonary infection. J Infect Dis 191, 1287-1291

42 Y. Terao (2006) Multifunctional glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pyogenes is essential for evasion from neutrophils. J Biol Chem 281, 14215-14223

43 J.N. Cole (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB J 20, 1745-1747

44 K.N. Seifert (2003) Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can J Microbiol 49, 350-356

45 V. Magalhaes (2007) Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect 9, 1276-1284

46 M. Soriani (2006) Group B Streptococcus crosses human epithelial cells by a paracellular route. J Infect Dis 193, 241-250

47 R. Maruvada , A.M. Blom and N.V. Prasadarao (2008) Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology 124, 265-276

48 H.J. Jennings (1983) Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry 22, 1258-1264

52 G. Kogan (1995) Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr Res 277, 1-9

53 G. Kogan (1996) Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide. J Biol Chem 271, 8786-8790

54 H.C. Slotved (2007) Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol 45, 2929-2936

57 M.A. Segura , P. Cleroux and M. Gottschalk (1998) Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol Med Microbiol 21, 189-195

59 I. Santi (2007) BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Mol Microbiol 63, 754-767

60 H. Jarva (2004) The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J Immunol 172, 3111-3118

61 P.G. Jerlstrom , G.S. Chhatwal and K.N. Timmis (1991) The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol 5, 843-849

62 T.O. Harris (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest 111, 61-70

63 P. Cornacchione (1998) Group B streptococci persist inside macrophages. Immunology 93, 86-95

64 C.F. Teixeira (2001) Cytochemical study of Streptococcus agalactiae and macrophage interaction. Microsc Res Tech 54, 254-259

65 C.B. Wilson and W.M. Weaver (1985) Comparative susceptibility of group B streptococci and Staphylococcus aureus to killing by oxygen metabolites. J Infect Dis 152, 323-329

66 C. Poyart (2001) Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun 69, 5098-5106

67 B. Spellerberg (2000) The cyl genes of Streptococcus agalactiae are involved in the production of pigment. FEMS Microbiol Lett 188, 125-128

68 G.Y. Liu (2004) Sword and shield: linked group B streptococcal β-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A 101, 14491-14496

69 R.L. Gallo and V. Nizet (2003) Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr Allergy Asthma Rep 3, 402-409

70 C. Poyart (2001) Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J Bacteriol 183, 6324-6334

71 A. Hamilton (2006) Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides. Infect Immun 74, 6179-6187

72 A.L. Jones (2007) A streptococcal penicillin-binding protein is critical for resisting innate airway defenses in the neonatal lung. J Immunol 179, 3196-3202

73 H.C. Maisey (2008) A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J 22, 1715-1724

74 G.C. Ulett (2005) Mechanisms of group B streptococcal-induced apoptosis of murine macrophages. J Immunol 175, 2555-2562

75 K. Fettucciari (2006) Group B Streptococcus induces macrophage apoptosis by calpain activation. J Immunol 176, 7542-7556

76 G.C. Ulett (2003) Beta-hemolysin-independent induction of apoptosis of macrophages infected with serotype III group B streptococcus. J Infect Dis 188, 1049-1053

77 A.F. Carlin (2007) Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J Bacteriol 189, 1231-1237

78 J. Rojas (1983) Pulmonary hemodynamic and ultrastructural changes associated with Group B streptococcal toxemia in adult sheep and newborn lambs. Pediatr Res 17, 1002-1008

79 J.D. Vallette Jr. (1995) Effect of an interleukin-1 receptor antagonist on the hemodynamic manifestations of group B streptococcal sepsis. Pediatr Res 38, 704-708

82 J.G. Vallejo , C.J. Baker and M.S. Edwards (1996) Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J Infect Dis 174, 332-337

83 G. Mancuso (2004) Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J Immunol 172, 6324-6329

84 P. Henneke (2008) Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180, 6149-6158

85 P. Henneke (2005) Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174, 6449-6455

86 S. Kenzel (2006) c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis. J Immunol 176, 3181-3188

88 A. Ring (2002) Synergistic action of nitric oxide release from murine macrophages caused by group B streptococcal cell wall and beta-hemolysin/cytolysin. J Infect Dis 186, 1518-1521

91 O. Levy (2003) Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect Immun 71, 6344-6353

93 P. Henneke (2002) Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 169, 3970-3977

94 M. Puliti (2000) Severity of group B streptococcal arthritis is correlated with β-hemolysin expression. J Infect Dis 182, 824-832

95 A. Ring (2002) Group B streptococcal β-hemolysin induces mortality and liver injury in experimental sepsis. J Infect Dis 185, 1745-1753

97 M.E. Hensler , S. Miyamoto and V. Nizet (2008) Group B streptococcal β-hemolysin/cytolysin directly impairs cardiomyocyte viability and function PLoS One 3, e2446

98 J. Quirante , R. Ceballos and G. Cassady (1974) Group B β-hemolytic streptococcal infection in the newborn. I. Early onset infection. Am J Dis Child 128, 659-665

101 K.S. Doran (2005) Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 115, 2499-2507

102 T. Tenenbaum (2005) Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect Immun 73, 4404-4409

103 K.S. Doran , G.Y. Liu and V. Nizet (2003) Group B streptococcal β-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 112, 736-744

104 S. Shin (2006) Focal adhesion kinase is involved in type III group B streptococcal invasion of human brain microvascular endothelial cells. Microb Pathog 41, 168-173

105 S. Shin and K.S. Kim (2006) RhoA and Rac1 contribute to type III group B streptococcal invasion of human brain microvascular endothelial cells. Biochem Biophys Res Commun 345, 538-542

106 Y.S. Kim (1995) Brain injury in experimental neonatal meningitis due to group B streptococci. J Neuropathol Exp Neurol 54, 531-539

107 M. Wahl (1988) Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 8, 621-634

108 M. Glibetic (2001) Group B Streptococci and inducible nitric oxide synthase: modulation by nuclear factor kappa B and ibuprofen. Semin Perinatol 25, 65-69

109 A.A. McKnight (1992) Oxygen free radicals and the cerebral arteriolar response to group B streptococci. Pediatr Res 31, 640-644

110 I. Bogdan (1997) Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 176, 693-697

111 K.S. Kim , C.A. Wass and A.S. Cross (1997) Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat. Exp Neurol 145, 253-257

112 S. Lehnardt (2006) A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol 177, 583-592

113 S. Lehnardt (2007) TLR2 and caspase-8 are essential for group B Streptococcus-induced apoptosis in microglia. J Immunol 179, 6134-6143

114 E.W. Ling (1995) Biochemical mediators of meningeal inflammatory response to group B streptococcus in the newborn piglet model. Pediatr Res 38, 981-987

115 L.C. Paoletti and D.L. Kasper (2002) Conjugate vaccines against group B Streptococcus types IV and VII. J Infect Dis 186, 123-126

116 L.C. Paoletti and D.L. Kasper (2003) Glycoconjugate vaccines to prevent group B streptococcal infections. Expert Opin Biol Ther 3, 975-984

117 C.J. Baker and M.S. Edwards (2003) Group B streptococcal conjugate vaccines. Arch Dis Child 88, 375-378

118 A.L. Lewis , V. Nizet and A. Varki (2004) Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A 101, 11123-11128

119 D.A. Santillan , M.E. Andracki and S.K. Hunter (2008) Protective immunization in mice against group B streptococci using encapsulated C5a peptidase. Am J Obstet Gynecol 198, 114 e111-116

120 B.R. Brodeur (2000) Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun 68, 5610-5618

121 S. Buccato (2006) Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J Infect Dis 194, 331-340

122 S. Patten (2006) Vaccination for Group B Streptococcus during pregnancy: attitudes and concerns of women and health care providers. Soc Sci Med 63, 347-358

123 L. Chohan (2006) Patterns of antibiotic resistance among group B Streptococcus isolates: 2001–2004. Infect Dis Obstet Gynecol 2006, 57492

124 S. Dahesh (2008) Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 52, 2915-2918

125 K. Kimura (2008) First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52, 2890-2897

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 10
Total number of PDF views: 37 *
Loading metrics...

Abstract views

Total abstract views: 311 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 25th June 2017. This data will be updated every 24 hours.